FOXO Technologies Inc. (ticker: FOXO) is an insurtech company operating in the life insurance sector, focused on applying epigenomics and artificial intelligence to underwriting and policyholder engagement. The company went public through a de-SPAC merger with CF Acquisition Corp. VIII, sponsored by Cantor Fitzgerald, which completed its IPO in 2021. This 10-Q filing, submitted August 16, 2021 under accession 0001213900-21-042948, reflects FOXO's financial disclosures ahead of that combination. The merger closed in September 2022, and FOXO subsequently listed on the NYSE American exchange. For full filing history, deal terms, and real-time SPAC analytics on FOXO and hundreds of comparable transactions, sign up for complete data access on SpacDesk.